AUTHOR=Dooley Sarah A. , Anderson Carryn M. 

TITLE=Definitive IMRT for Stage III Thymic Carcinoma: A Brief Report and Literature Review

JOURNAL=Frontiers in Oncology

VOLUME=6

YEAR=2016

URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2016.00219

DOI=10.3389/fonc.2016.00219

ISSN=2234-943X

ABSTRACT=<sec id="ST1"><title>Introduction</title><p>Thymic carcinoma is a rare malignancy often presenting at an advanced stage. Radiation therapy and chemotherapy are often the only treatment options available to physicians.</p></sec><sec id="ST2"><title>Methods</title><p>A 70-year-old man presented with an unresectable stage III thymic tumor and was treated with 45 Gy in 25 fractions followed by a boost of 21.6 Gy in 12 fractions. He was also treated with bortezomib for multiple myeloma unrelated to his primary malignancy.</p></sec><sec id="ST3"><title>Results</title><p>The patient made a full recovery following the radiation regimen and remained disease free 4 years after the treatment.</p></sec><sec id="ST4"><title>Conclusion</title><p>Exclusive treatment with intensity-modulated radiation therapy provides a viable treatment option for patients presenting with advanced stage thymic carcinoma.</p></sec>